5. NGHIÊN CỨU ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐÁNH GIÁ KẾT QUẢ SỚM ĐIỀU TRỊ UNG THƯ BÀNG QUANG THỂ CHƯA XÂM LẤN CƠ TẠI CẦN THƠ GIAI ĐOẠN 2021-2023

Abstract

Aim: (1) Survey of clinical and paraclinical characteristics of non-muscle invasive bladder cancer at Can Tho Central General Hospital in 2021-2023; (2) Evaluate early results of treatment for nonmuscle invasive bladder cancer at Can Tho Central General Hospital in 2021-2023.

Methods: Descriptive retrospective combined with prospective studies on 45 patients aged 16 years and older with non-muscle invasive bladder cancer treated at Can Tho Central General Hospital from January 2021 to December 2023.

Results: Men account for a high proportion of 88.89%. The age group with the highest percentage is the group from 61 - 80 years old, accounting for 62.22%. Symptoms of mild anemia account for 20%. There are 97.78% of ultrasound cases that detect tumors through ultrasound. Tumor size on ultrasound and abdominal CT-Scan are 81.82% similar. Bladder tumors at stage Ta account for 55.56%, with G1 differentiation accounting for 62.22%. Side effects of burning and painful urination accounted for 13.33% and side effects of pain in the lower abdomen accounted for a low rate of 2.22% after adjuvant treatment with Doxorubicin. Surgical results: mostly good results 95.56%, no cases of bad results.

Conclusion: Laparoscopic resection of non-muscle invasive bladder tumors through the urethra is a safe method and should be widely applied in Can Tho.